BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFN&ggr;–STAT1–IRF1–p53 axis in diffuse large B-cell lymphoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cell Science

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1242/jcs.118174PMID 23487038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Arginine methyltransferase CARM 1 is a promoter-specific regulator of NF-j B-dependent gene expression

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Interferon / Stat 1 Pathway : Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth

  2012cited by this paper
• Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma

  2012cited by this paper
• Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

  2012cited by this paper
• Pathogenesis of human B cell lymphomas.

  2012cited by this paper
• Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA.

  2012cited by this paper
• FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

  2012cited by this paper
• Molecular Profiling

  2012cited by this paper
• HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

  2011cited by this paper
• Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.

  2011cited by this paper
• Oncogenically active MYD88 mutations in human lymphoma

  2011cited by this paper
• Restoration of IFNγR Subunit Assembly, IFNγ Signaling and Parasite Clearance in Leishmania donovani Infected Macrophages: Role of Membrane Cholesterol

  2011influential reference
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer

  2011influential reference
• FBXO 11 targets BCL 6 for degradation and is inactivated in diffuse large B-cell lymphomas

  2011cited by this paper
• Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes.

  2011influential reference
• Toward a unified nomenclature for mammalian ADP-ribosyltransferases.

  2010cited by this paper
• Method for the synthesis of mono-ADP-ribose conjugated peptides.

  2010cited by this paper
• Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

  2010cited by this paper
• BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

  2009influential reference
• Advances in the biology and therapy of patients with chronic myeloid leukaemia.

  2009influential reference
• STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy

  2009cited by this paper
• PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

  2009cited by this paper
• A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation

  2009influential reference
• CDK5-dependent Phosphorylation of the Rho Family GTPase TC10α Regulates Insulin-stimulated GLUT4 Translocation*

  2008influential reference
• CDK 5-dependent Phosphorylation of the Rho Family GTPase TC 10 Regulates Insulin-stimulated GLUT 4 Translocation *

  2008influential reference
• Host immune response in B-cell lymphomas: friend or foe?

  2008cited by this paper
• Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene.

  2008cited by this paper
• An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

  2008cited by this paper
• A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

  2007cited by this paper
• Collaborator of Stat6 (CoaSt6)-associated Poly(ADP-ribose) Polymerase Activity Modulates Stat6-dependent Gene Transcription*

  2007cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only.

  2007influential reference
• Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.

  2007influential reference
• Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells

  2007cited by this paper
• BAL1 and BBAP Are Regulated by a Gamma Interferon-Responsive Bidirectional Promoter and Are Overexpressed in Diffuse Large B-Cell Lymphomas with a Prominent Inflammatory Infiltrate

  2006influential reference
• Interferons, immunity and cancer immunoediting

  2006cited by this paper
• Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155

  2006cited by this paper
• The role of IRF1 and IRF2 transcription factors in leukaemogenesis.

  2006influential reference
• Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor.

  2006cited by this paper
• B-aggressive Lymphoma Family Proteins Have Unique Domains That Modulate Transcription and Exhibit Poly(ADP-ribose) Polymerase Activity*

  2005influential reference
• Acetylation of Poly(ADP-ribose) Polymerase-1 by p300/CREB-binding Protein Regulates Coactivation of NF-κB-dependent Transcription*

  2005influential reference
• Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.

  2005influential reference
• Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression

  2005cited by this paper
• Identification of novel and cell type enriched cofactors of the transcription activation domain of RelA (p65 NF-kappaB).

  2005cited by this paper
• Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

  2004cited by this paper
• Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site

  2004cited by this paper
• STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.

  2004cited by this paper
• STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis*

  2004cited by this paper
• Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells.

  2004cited by this paper
• The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

  2004cited by this paper
• The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell Death*

  2003cited by this paper
• DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

  2003cited by this paper
• Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions

  2003cited by this paper
• Distinct transcriptional activation functions of STAT1alpha and STAT1beta on DNA and chromatin templates.

  2003cited by this paper
• Distinct Transcriptional Activation Functions of STAT1α and STAT1β on DNA and Chromatin Templates*

  2003cited by this paper
• IFN-gamma suspends the killing license of anti-tumor CTLs.

  2002cited by this paper
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

  2002cited by this paper
• Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

  2002cited by this paper
• IFN-γ suspends the killing license of anti-tumor CTLs

  2002cited by this paper
• IRF family of transcription factors as regulators of host defense.

  2001cited by this paper
• Serine phosphorylation of STATs

  2000cited by this paper
• Regulation of STAT1 Nuclear Export by Jak1

  2000cited by this paper
• BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.

  2000influential reference
• Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.

  1999cited by this paper
• Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31)

  1999cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Eukaryotic gene transcription with purified components.

  1983cited by this paper

• ITLN1, orchestrated by the IFNγ-IRF1 axis, suppresses hepatocellular carcinoma proliferation via ERK1/2 activation

  2025cites this paper
• Mono-ADP-ribosylating PARP enzymes in cellular signaling and disease

  2025cites this paper
• BALs are prognostic biomarkers and correlate with malignant behaviors in breast cancer

  2025cites this paper
• The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications

  2025cites this paper
• PARP9 exacerbates apoptosis and neuroinflammation via the PI3K pathway in the thalamus and hippocampus and cognitive decline after cortical infarction

  2025cites this paper
• PARPs and PARP inhibitors: molecular mechanisms and clinical applications

  2025cites this paper
• Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities

  2025cites this paper
• PARP9: A novel biomarker for predicting poor prognosis in pancreatic adenocarcinoma.

  2024cites this paper
• Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities

  2024cites this paper
• PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology

  2024cites this paper
• Transcriptomics explores potential mechanisms for the development of Primary Sjogren’s syndrome to diffuse large B-cell lymphoma in B cells

  2024cites this paper
• ADP-ribosylation, a multifaceted modification: functions and mechanisms in aging and aging-related diseases.

  2024cites this paper
• Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms

  2024cites this paper
• Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphoma

  2024cites this paper
• Extracellular vesicles derived from HuMSCs alleviate daunorubicin-induced cardiac microvascular injury via miR-186-5p/PARP9/STAT1 signal pathway

  2024cites this paper
• KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein–Protein Interactions to Promote Cancer Cell Survival

  2024cites this paper
• IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment.

  2023cites this paper
• Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs

  2023cites this paper
• Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker

  2023cites this paper
• IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors

  2022cites this paper
• Functional roles of ADP-ribosylation writers, readers and erasers

  2022cites this paper
• Reconstitution of the DTX3L-PARP9 complex reveals determinants for high affinity heterodimerization and multimeric assembly.

  2022cites this paper
• Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

  2022cites this paper
• Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics

  2022cites this paper
• Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.

  2022cites this paper
• IFNγ‐mediated repression of system xc− drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells

  2021cites this paper
• Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells

  2021cites this paper
• Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer

  2021cites this paper
• Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly

  2021cites this paper
• Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses

  2021cites this paper
• Reconstitution of the DTX3L-PARP9 complex reveals determinants for high affinity heterodimer formation and enzymatic function

  2021cites this paper
• Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target

  2020cites this paper
• Novel Targets and Biomarkers in Solid Tumors

  2020cites this paper
• Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype

  2020cites this paper
• Cross-talk between Myc and p53 in B-cell lymphomas

  2019cites this paper
• Research Progress on PARP14 as a Drug Target

  2019cites this paper
• ADP-ribosylation signalling and human disease

  2019cites this paper
• The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression

  2019cites this paper
• IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ.

  2019cites this paper
• Poly(ADP‐Ribose) Polymerase Enhances Infiltration of Mononuclear Cells in Primary Sjögren's Syndrome Through Interferon‐Induced Protein With Tetratricopeptide Repeats 1–Mediated Up‐Regulation of CXCL10

  2019cites this paper
• PARPs in genome stability and signal transduction: implications for cancer therapy

  2018cites this paper
• Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients.

  2018cites this paper
• PARP9 is overexpressed in human breast cancer and promotes cancer cell migration.

  2018cites this paper
• IRF1 up‐regulates isg15 gene expression in dsRNA stimulation or CSFV infection by targeting nucleotides −487 to −325 in the 5′ flanking region

  2018cites this paper
• Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation

  2018cites this paper
• Dynamic changes and molecular analysis of cell death in the spinal cord of SJL mice infected with the BeAn strain of Theiler’s murine encephalomyelitis virus

  2018cites this paper
• ADP-Ribosylation of the Ubiquitin C-Terminus by Dtx3L/Parp9

  2018cites this paper
• Novel approach to cancer therapeutics using comparative cancer biology

  2018cites this paper
• The ADP-Ribosyl-Transferases Diphtheria Toxin-Like (ARTDs) Family: An Overview

  2018cites this paper
• Study of the Cellular Role of GRP78/BiP mono-ADP-ribosylation in UPR and Cancer

  2018cites this paper
• PARP 9 is overexpressed in human breast cancer and promotes cancer cell migration

  2018cites this paper
• MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type

  2018cites this paper
• The regulation of the ADP-ribosyl-hydrolase MacroD2 upon DNA damage

  2017cites this paper
• Current Progress in EBV-Associated B-Cell Lymphomas.

  2017cites this paper
• Expanding functions of ADP-ribosylation in the maintenance of genome integrity.

  2017cites this paper
• Robust immunoglobulin class switch recombination and end joining in Parp9‐deficient mice

  2017cites this paper
• Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.

  2017cites this paper
• Players in ADP-ribosylation: Readers and Erasers.

  2016cites this paper
• Genetic Association of PARP15 Polymorphisms with Clinical Outcome of Acute Myeloid Leukemia in a Korean Population

  2016cites this paper
• Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes

  2016cites this paper
• Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients

  2016cites this paper
• Macrodomains: Structure, Function, Evolution, and Catalytic Activities.

  2016cites this paper
• PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation

  2016cites this paper
• Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents

  2016cites this paper
• Intracellular Mono-ADP-Ribosylation in Signaling and Disease

  2015cites this paper
• Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

  2015influential citation
• Identification and characterization of novel recurrent mutations in primary mediastinal large B cell lymphoma and Hodgkin lymphoma.

  2015cites this paper
• Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data

  2015cites this paper
• Discovery of the PARP Superfamily and Focus on the Lesser Exhibited But Not Lesser Talented Members

  2015cites this paper
• PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

  2015cites this paper
• RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

  2014cites this paper
• РЕГУЛЯЦИЯ ПРОЛИФЕРАТИВНОЙ АКТИВНОСТИ ЭПИТЕЛИЕВ

  2014cites this paper
• Role of TIP5 in metastatic prostate cancer and osteosarcoma cells

  2014cites this paper
• DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells

  2014cites this paper